NCT01969916View on ClinicalTrials.gov

Stress CT Perfusion in Patients With Chest Pain

NACompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions

Coronary Artery Disease

Interventions

DRUG

Regadenoson

Patients will be given a single dose of Lexiscan (0.4 mg, iv bolus)

Trial Locations (1)

60637

University of Chicago Medical Center, Chicago

Sponsors

Collaborators (1)

Astellas Pharma Inc

All Listed Sponsors

collaborator

Astellas Pharma Inc

INDUSTRY

lead

University of Chicago

OTHER